Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.01
-0.10 (-1.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $773.2 million as of July 31, 2026. Its market cap has increased by 89.23% in one year.
Market Cap
773.20M
Enterprise Value
675.46M
1-Year Change
89.23%
Ranking
Category
Stock Price
$7.01
ChartMarket Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $773.20M, an increase of 94.40%. That is a compound annual growth rate of 15.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 773.20M | 123.41% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 835.84M |
| Kura Oncology | 826.49M |
| DBV Technologies | 812.86M |
| Design Therapeutics | 788.21M |
| Tenax Therapeutics | 771.49M |
| Monopar Therapeutics | 768.08M |
| SpyGlass Pharma | 759.61M |
| Aclaris Therapeutics | 743.01M |